NeuroOne Medical Technologies CorporationNN

NeuroOne Medical Technologies Corporation

1.12USDR
+0.01+0.41%
At close at Mar 1, 00:28 GMT
USD
No trades
See on Supercharts

NMTC fundamentals

Key facts

Market capitalization‪34.41 M‬USD
Basic EPS (TTM)−0.27USD
Founded2009
CEODavid A. Rosa
Websiten1mtc.com
About

NeuroOne Medical Technologies Corp. is a medical technology company, which engages in the development and commercialization of thin film electrode technology for continuous electroencephalogram and stereoelectrocencephalography recording, spinal cord stimulation, brain stimulation, and ablation solutions. The company was founded by Mark Christianson on August 20, 2009 and is headquartered in Eden Prairie, MN.

Ownership
‪‪30.86 M‬‬
Free Float shares
‪‪26.76 M‬‬ (86.69%)
Closely held shares
‪‪4.11 M‬‬ (13.31%)
Free Float shares
‪‪26.76 M‬‬ (86.69%)
Closely held shares
‪‪4.11 M‬‬ (13.31%)
Capital structure
Market cap
‪‪34.41 M‬‬
Debt
‪‪341.51 K‬‬
Cash & equivalents
‪‪1.13 M‬‬
Enterprise value
‪‪33.62 M‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪34.41 M‬‬
Price to earning ratio (P/E)
Price to sales ratio (P/S)
3.92x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
Price to sales ratio (P/S)
3.92x
Valuation ratios
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪3.50‬
‪7.00‬
‪10.50‬
‪14.00‬
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−1,350.00%‬
‪−900.00%‬
‪−450.00%‬
‪0.00%‬
‪450.00%‬
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪‪−7.00 M‬‬
‪‪−3.50 M‬‬
‪0.00‬
‪‪3.50 M‬‬
‪‪7.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪1.60 M‬‬
‪‪3.20 M‬‬
‪‪4.80 M‬‬
‪‪6.40 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪1.60 M‬‬
‪‪3.20 M‬‬
‪‪4.80 M‬‬
‪‪6.40 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Strip/Grid Products, Stereoelectrocencephalography Products and Electrode Cable Assembly Products
By country
Period: 2024
United States

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
‪0.00‬
‪‪1.60 M‬‬
‪‪3.20 M‬‬
‪‪4.80 M‬‬
‪‪6.40 M‬‬
Actual
Estimate
Earnings
Next:May 8, 2025
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
‪−0.12‬
‪−0.06‬
‪0.00‬
‪0.06‬
‪0.12‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

NMTC does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪‪−4.00 M‬‬
‪‪−2.00 M‬‬
‪0.00‬
‪‪2.00 M‬‬
‪‪4.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪1.50 M‬‬
‪‪3.00 M‬‬
‪‪4.50 M‬‬
‪‪6.00 M‬‬
Assets
Liabilities